Tempus

Clinical Account Executive, East Tennessee

Tennessee, United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Information TechnologyIndustries

Requirements

Candidates must possess the ability to provide an integrated MolDx/SaaS solution using Tempus’s sequencing technology, engage in consultative selling, and sell at the executive level. A keen understanding of the payor and reimbursement environment in oncology and diagnostics is required, along with the ability to work independently, manage multiple projects, and prioritize tasks. Strong knowledge of molecular diagnostics for oncology, oncology, hematology, chemotherapeutics, targeted agents, negotiation, customer service, and strategic sales account planning are essential. Proficiency in Microsoft Office Suite, particularly Excel and PowerPoint, and regular utilization of Salesforce.com are necessary. Advanced presentation skills, business acumen, problem-solving abilities, and strong administrative skills are also required.

Responsibilities

The Clinical Account Executive will drive strategic business expansion and collaboration opportunities with major U.S. cancer centers, clinics, Key Opinion Leaders, and Academic Medical Centers within the East Tennessee territory. Responsibilities include structuring detailed strategic plans for client acquisition and retention, maximizing client-bill contracting opportunities, and implementing laboratory services agreements. The role involves collaborating with sales positions to achieve company goals, identifying partnering opportunities, promoting compliance with web-based molecular information tools, and analyzing the competitive landscape. The executive will monitor sales performance, develop and implement a comprehensive business plan for the territory, and work effectively with individuals across multiple departments. They will embrace and represent the Tempus company culture and travel frequently throughout the territory.

Skills

precision medicine
healthcare industry
AI
clinical care
real-world evidence
molecular information tools
MolDx
SaaS
sequencing technology
business expansion
strategic planning
client retention
contracting
laboratory services agreements
sales coordination
competitive analysis
territory management
business planning

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters
2015Year Founded
$894.9MTotal Funding
IPOCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Relocation Assistance
Company Equity
Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.
Ambry Genetics acquisition could pose financial risks if synergies aren't realized.
Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.
Their platform aids in personalized treatment decisions for cancer patients.
Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.
Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.
Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI